home / stock / cbis / cbis news


CBIS News and Press, Cannabis Science Inc From 03/19/18

Stock Information

Company Name: Cannabis Science Inc
Stock Symbol: CBIS
Market: OTC

Menu

CBIS CBIS Quote CBIS Short CBIS News CBIS Articles CBIS Message Board
Get CBIS Alerts

News, Short Squeeze, Breakout and More Instantly...

CBIS - Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers

IRVINE, CA, March 19, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis Science has acquired Bottle It, Inc., located in Corona, California. Bottle It is Southern C...

CBIS - Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus' Newly Acquired Cannabia, The World's First Cannabis Beer

IRVINE, CA, March 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis Science enters the multi-billion USD beverage industry as it partners with Crown Baus Capita...

CBIS - Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals

Grand Opening of First CBIS Pharmacies Expected Soon IRVINE, CA, March 05, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company’s first two PRE-ICO, medic...

CBIS - Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social Media Educational Website

IRVINE, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the beta launch of iCannabinoid, the Company’s state-of-the-art, high technology social media an...

CBIS - Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options

IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the Company’s groundbreaking laboratory research with Dana-Farber Cancer Institute using Nanopart...

CBIS - 269 Marijuana Stocks: Correction, Crash, Or Slow Descent?

The Macroeconomic Outlook and Marijuana Stocks Diversify, but with a long-term focus on the horizon. Equities will remain good, and cannabis and marijuana stocks should remain and represent a significant part of your long-term investment portfolio. Presently, they are likely to be fairly val...

CBIS - Cannabinoids Lead to Marijuana Biotech Boom

NetworkNewsWire Editorial Coverage : As the legalization of medical marijuana spreads, the appetite for investment in the cannabis biotech sector keeps growing. This is the largest sector of the legal cannabis market, already a multi-billion-dollar market. Researchers continue to uncover new ...

CBIS - 268 Marijuana Stocks: Learn From An Examination Of Event Dates For The Prior 52 Weeks

History Repeats This article is designed to assist you with decision-making when deciding when to [1] enter, [2] exit, and [3] whether to hold through future statements made by U.S. Attorney General Jeff Sessions and [4] January Effects. I still anticipate an upward drift for the sector th...

CBIS - Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers

IRVINE, CA , Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, has entered into an expanded 5-year, $1.8 million Research Collaboration Agreement (RCA) with Dana Farber Cancer Institute, In...

CBIS - San Francisco dismisses marijuana convictions

Model for other U.S. districts? San Francisco will expunge and dismiss thousands of misdemeanor and felony marijuana convictions for those sentenced prior to the legalization of marijuana in California. More news on: Aurora Cannabis Inc., Aero Grow International, Inc., American Cannabis ...

Previous 10 Next 10